Dr. Preeti A. Reshamwala, MD

Dr. Reshamwala practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Reshamwala's NPI, 1578604583, was assigned on February 11, 2007. Dr. Reshamwala graduated from Wayne State University School of Medicine in 2001. Dr. Reshamwala holds Georgia license A116653.

Dr. Reshamwala's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Reshamwala's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Reshamwala is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Reshamwala to 2 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reshamwala practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reshamwala's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Reshamwala is licensed in Georgia.

CMS data shows 267 Medicare services from Dr. Reshamwala across 8 procedure codes in 2024, for 187 Medicare patients. Medicare paid $20,042 for them.

CMS counts 187 Medicare patients who saw Dr. Reshamwala in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reshamwala's median patient age at 61, with 54% women.

In 2024, Dr. Reshamwala wrote 996 Medicare Part D claims for 180 patients. 88% of them were for generic drugs. CMS names the drug for 781 of them, across 19 drugs with 11 or more claims each, at $407,831 in total drug cost. In 2023, CMS named 684 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Reshamwala for performance year 2024, reported through an alternative payment model (APM). Dr. Reshamwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reshamwala as offering telehealth. CMS counts 17 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reshamwala, more than 48% of the clinicians it reports for that procedure.

CMS Open Payments shows 2 general payments to Dr. Reshamwala from 2 drug and device companies from 2019 to 2024. Honoraria make up the largest share, 99% of the total. Intercept Pharmaceuticals, Inc. paid the most, $2,640.

Dr. Reshamwala graduated from Wayne State University School of Medicine in 2001.